- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Denosumab – July 2016
Denosumab: 120 mg/1.7 mL injection, 1 × 1.7 mL vial, Xgeva®
Last updated
28 October 2016